Literature DB >> 31595086

As CBD skyrockets in popularity, scientists scramble to understand how it's metabolized.

Amber Dance.   

Abstract

Keywords:  Drug discovery; Medical research; Toxicology

Mesh：

Substances：

Year:  2019        PMID： 31595086     DOI： 10.1038/d41591-019-00018-5

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

Review 1.  Practical considerations in medical cannabis administration and dosing.

Authors:  Caroline A MacCallum; Ethan B Russo
Journal:  Eur J Intern Med       Date:  2018-01-04       Impact factor: 4.487

2.  The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.

Authors:  Yuli Qian; Bill J Gurley; John S Markowitz
Journal:  J Clin Psychopharmacol       Date:  2019 Sep/Oct       Impact factor: 3.153

3.  Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Authors:  Zheng Liu; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

Review 4.  Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  Annu Rev Neurosci       Date:  2016-02-24       Impact factor: 12.449

5.  Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.

Authors:  Antonio W Zuardi; Natália P Rodrigues; Angélica L Silva; Sandra A Bernardo; Jaime E C Hallak; Francisco S Guimarães; José A S Crippa
Journal:  Front Pharmacol       Date:  2017-05-11       Impact factor: 5.810

6.  Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.

Authors:  Fabricio A Pamplona; Lorenzo Rolim da Silva; Ana Carolina Coan
Journal:  Front Neurol       Date:  2018-09-12       Impact factor: 4.003

7.  A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Authors:  Sophie A Millar; Nicole L Stone; Andrew S Yates; Saoirse E O'Sullivan
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

8.  A systematic review of cannabidiol dosing in clinical populations.

Authors:  S A Millar; N L Stone; Z D Bellman; A S Yates; T J England; S E O'Sullivan
Journal:  Br J Clin Pharmacol       Date:  2019-07-19       Impact factor: 4.335

9.  A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.

Authors:  Lesley Taylor; Barry Gidal; Graham Blakey; Bola Tayo; Gilmour Morrison
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.